CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: A Phase II Study of M2951 in SLE [Phase 2]
Summary
Phase II study of M2951 in systemic lupus erythematosus was terminated; results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2020-12-17